IP Verse

Administration Of Deuterated Cftr Potentiators

Patent No. EP3352757 (titled "Administration Of Deuterated Cftr Potentiators") was filed by Vertex Pharmaceuticals Europe on Sep 21, 2016. The application was issued on Aug 16, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMay 16, 2024TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3352757

VERTEX PHARMACEUTICALS EUROPE
Application Number
EP16849524A
Filing Date
Sep 21, 2016
Status
Granted And Under Opposition
Jul 14, 2023
Publication Date
Aug 16, 2023
External Links
Slate, Register , Google Patents